Q: GILD is down 10% after its phase 3 trial of Trodelvy in a lung cancer trial failed to meet its primary end-point. Is this just "noise" or a reason for a long-term shareholder to sell?
-
Gilead Sciences Inc. (GILD)
-
AbbVie Inc. (ABBV)
-
Abbott Laboratories (ABT)
-
Johnson & Johnson (JNJ)
-
Eli Lilly and Company (LLY)
-
Merck & Company Inc. (MRK)
-
Pfizer Inc. (PFE)
-
WELL Health Technologies Corp. (WELL)
Q: Hi folks,
I am looking to replace GILD in my TFSA. I currently hold ABBV, LLY, PFE and WELL in other accounts. I am looking for a name that pays a good dividend and has some potential for growth. Can you suggest a couple of names I can take a look at or should I add one of the names I already hold.
Thanks
I am looking to replace GILD in my TFSA. I currently hold ABBV, LLY, PFE and WELL in other accounts. I am looking for a name that pays a good dividend and has some potential for growth. Can you suggest a couple of names I can take a look at or should I add one of the names I already hold.
Thanks
Q: GILD delivers an earnings beat and then the stock falls by $5 over the next couple of days. What is going on? Do you still like it for the long term?